Board appointment at Ardea Biosciences
This article was originally published in Scrip
Executive Summary
Ardea Biosciences (US) has appointed Dr Felix Baker to its board of directors. Dr Baker is a managing partner of Baker Bros. Advisors, the manager and advisor to the funds of Baker Brothers Investments, Ardea's largest shareholder. Ardea is a California-based biotech company focused on the development of small-molecule therapeutics for the treatment of gout, cancer and HIV.